Cargando…
Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551417/ https://www.ncbi.nlm.nih.gov/pubmed/37810555 http://dx.doi.org/10.1155/2023/9787264 |
| _version_ | 1785115761306501120 |
|---|---|
| author | Longevity, Oxidative Medicine and Cellular |
| author_facet | Longevity, Oxidative Medicine and Cellular |
| author_sort | Longevity, Oxidative Medicine and Cellular |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10551417 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105514172023-10-06 Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide Longevity, Oxidative Medicine and Cellular Oxid Med Cell Longev Retraction Hindawi 2023-09-27 /pmc/articles/PMC10551417/ /pubmed/37810555 http://dx.doi.org/10.1155/2023/9787264 Text en Copyright © 2023 Oxidative Medicine and Cellular Longevity. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Longevity, Oxidative Medicine and Cellular Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide |
| title | Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide |
| title_full | Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide |
| title_fullStr | Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide |
| title_full_unstemmed | Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide |
| title_short | Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide |
| title_sort | retracted: ttc7b is a novel prognostic-related biomarker in glioma correlating with immune infiltrates and response to oxidative stress by temozolomide |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551417/ https://www.ncbi.nlm.nih.gov/pubmed/37810555 http://dx.doi.org/10.1155/2023/9787264 |
| work_keys_str_mv | AT longevityoxidativemedicineandcellular retractedttc7bisanovelprognosticrelatedbiomarkeringliomacorrelatingwithimmuneinfiltratesandresponsetooxidativestressbytemozolomide |